05:25 PM EDT, 08/13/2026 (MT Newswires) -- Seres Therapeutics ( MCRB ) filed a registration statement late Thursday for the sale of $300 million of securities from time to time.
The securities cover common and preferred stocks, debt securities, warrants, and units.